Fine particle fraction drift during stability testing – device vs formulation investigation


Published on 02/01/2026

Investigation of Fine Particle Fraction Drift During Stability Testing: Device and Formulation Analysis

Fine particle fraction (FPF) drift during stability testing is a critical issue in the pharmaceutical manufacturing process, particularly for dry powder inhalers (DPIs). Anomalies related to FPF can affect the efficacy of the product, leading to product recalls or regulatory actions. This article outlines a structured approach for investigating FPF drift during stability testing, focusing on differential factors that could contribute to this manufacturing defect.

After reading this article, you will gain insights into identifying the signals of FPF drift, establishing likely root causes, implementing an effective containment strategy, and executing a well-defined CAPA plan. Additionally, we will elaborate on strategies to ensure inspection readiness, encompassing all aspects of documentation and evidence collection.

Symptoms/Signals on the Floor or in the Lab

Identifying symptoms early in the testing phase is crucial for preemptive action. Common symptoms of

FPF drift may include:

  • Inconsistent FPF readings across stability samples compared to initial baselines.
  • Increased variability between replicate measurements.
  • Unexplained deviations in particle size distribution over time.
  • Customer complaints regarding perceived efficacy post-stability testing.

Observations made during routine stability tests are key indicators that should trigger investigation protocols. Documenting all findings meticulously is essential for understanding trends and spotting abnormal patterns that could signify underlying issues regarding either the formulation or the device.

Likely Causes

When investigating FPF drift, it is pivotal to categorize the likely causes using the “5 Ms” framework: Materials, Method, Machine, Man, Measurement, and Environment.

Materials

  • Raw material inconsistencies.
  • Changes in the formulation composition.

Method

  • Variability in analytical procedures or equipment settings.
  • Improper handling of stability samples.

Machine

  • Functionality issues with the DPI delivery device.
  • Calibration issues of the testing apparatus.

Man

  • Human error in sampling or measurement procedures.
  • Insufficient training on stability testing protocols.
Pharma Tip:  Device assembly defect after device change – device vs formulation investigation

Measurement

  • Instrumental calibration and reliability impacting FPF readings.
  • Deficiencies in measurement method could lead to erroneous data.

Environment

  • Fluctuations in storage conditions (temperature, humidity).
  • Contaminations in the laboratory setting affecting results.

Each category must be further evaluated to rule out potential culprits systematically during the investigation process.

Immediate Containment Actions (first 60 minutes)

In the event of detecting FPF drift, immediate containment actions must be executed to limit impact:

  1. Quarantine the affected stability samples and any associated batches.
  2. Notify all relevant stakeholders including QA, production, and regulatory teams.
  3. Review and halt the distribution of any affected batches under investigation.
  4. Gather initial data including batch records and stability testing results to start documentation.

Quick containment aims to prevent further deviations and safeguard patient safety while the investigative procedures are underway.

Investigation Workflow (data to collect + how to interpret)

The investigation should follow a structured workflow comprising the following steps:

  1. Gather and review all relevant documentation—batch records, analytical results, and stability protocols.
  2. Collect additional data including environmental controls during stability testing and analytical measuring conditions.
  3. Engage cross-functional teams to provide insights from various domains (Quality, Manufacturing, Engineering).
  4. Identify trends in the data collected; evaluate where changes occurred and correlate with the timing of observed FPF drift.

Ensuring that this data collection is thorough and accurate aids in the identification of root causes and supports the CAPA process later in the investigation.

Root Cause Tools

Identifying the root cause of the deviation can be achieved using various tools:

5-Why Analysis

The 5-Why method involves iteratively asking “why” when identifying a problem, leading to deeper insights into underlying issues.

Fishbone Diagram

The Fishbone (Ishikawa) diagram helps to visually categorize potential causes of FPF drift and facilitates discussion in multidisciplinary teams.

Fault Tree Analysis

Fault Tree Analysis helps in deducing failures leading to the observed symptoms, especially when there are complex interdependencies involved.

Utilizing these tools under the right circumstances enhances the precision of determining the actual root cause of FPF drift, which is critical for designing effective corrective actions.

Pharma Tip:  Delivered dose uniformity failure after device change – CAPA control strategy gap

CAPA Strategy

The Corrective and Preventive Action (CAPA) strategy must address not only immediate corrective actions but also ensure systemic issues are resolved:

Correction

  • Verify testing methods and re-evaluate the affected batches.
  • Make adjustments to improve testing reliability and outcomes.

Corrective Action

  • Implement training sessions for staff involved in stability testing.
  • Validate the calibration and performance of testing equipment.

Preventive Action

  • Develop a standard operating procedure (SOP) that includes steps for handling potential FPF discrepancies.
  • Establish an ongoing monitoring framework to catch similar issues early.

A comprehensive CAPA not only solves the immediate issue but also strengthens quality systems to avert recurrence.

Control Strategy & Monitoring

A robust control strategy is essential for ongoing monitoring of FPF and other relevant parameters:

Related Reads

  • Implement Statistical Process Control (SPC) methods to track measurements over time for any deviations.
  • Utilize trending tools and sampling plans to ensure FPF remains within established limits.
  • Incorporate alarm systems to flag out-of-control conditions or unexpected variances during FPF measurements.

Routine verification of these control measures reinforces confidence in product quality and reliability.

Validation / Re-qualification / Change Control Impact

Should the investigation and its outcomes necessitate any changes in the formulation or devices used, appropriate validation and re-qualification activities must be initiated:

  • Re-qualify analytical methods impacted by changes to ensure continued compliance.
  • Document changes through rigorously tracked change control policies, ensuring all modifications are recorded in accordance with regulatory requirements.
  • Conduct validation studies if the underlying cause involves equipment or formulation modifications.

This step ensures that product integrity is maintained and regulatory expectations are met after changes are executed.

Inspection Readiness: What Evidence to Show

Ensuring inspection readiness through comprehensive documentation is vital:

  • Maintain detailed records of all stability testing, adjustments made during investigation, and data collected.
  • Prepare batch production records and logs showing adherence to testing protocols.
  • Document all investigations, including deviation reports, CAPA entries, and follow-up actions to present during inspections.

All documented evidence should be readily accessible and organized to facilitate smooth inspection processes by FDA, EMA, or MHRA representatives.

Pharma Tip:  Powder flow issue during inspection readiness – regulatory expectation mismatch

FAQs

What is fine particle fraction (FPF)?

FPF refers to the portion of aerosolized particles that are small enough to reach the deep lung upon inhalation, crucial for the efficacy of inhalation therapies.

How is FPF measured during stability testing?

FPF is measured using techniques such as cascade impaction, which assesses particle size distribution and ensures consistency over time.

What should I do if I observe FPF drift?

Immediately quarantine affected batches, notify relevant stakeholders, and start an investigation following established protocols.

How often should stability testing be conducted?

Stability testing frequency is generally dictated by regulatory guidelines but should align with product lifecycle stages and any substantial changes.

How can I ensure my investigation is thorough?

Involve cross-functional teams, gather comprehensive data, and utilize root cause analysis tools like 5-Whys and Fishbone diagrams.

When should I implement a CAPA plan?

A CAPA plan should be implemented once a root cause has been identified to address both correction and prevention of future occurrences.

What documentation is critical for regulatory inspections?

Maintain all records related to stability testing, investigations, CAPA actions, and any deviations in an organized format for review.

How do environmental conditions affect FPF during testing?

Environmental factors like humidity and temperature can significantly impact formulations and compromise testing results, affecting overall stability.

Can FPF drift occur without formulation changes?

Yes, FPF drift can stem from variances in testing methods, equipment calibration issues, or environmental factors unrelated to the formulation.

What are the regulatory expectations for stability testing documentation?

Regulatory bodies expect complete and accurate documentation of all testing phases, methodologies, and any anomalies, to support product safety and efficacy.

How frequently should training be updated for staff involved in stability testing?

Training should be updated regularly and whenever there are significant changes to procedures, equipment, or team members to ensure compliance and effectiveness.

What types of changes require re-qualification of equipment?

Changes such as equipment upgrades, modifications in usage protocols, or significant drift in performance metrics often necessitate re-qualification.